Scientific Articles

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin

23 Nov 2022

 

R Iacovelli, C Ciccarese, M Brunelli, N Battelli, C Buttigliero, C Caserta, S Buti, D Santini, C Carella, L Galli, E Verri, P Ermacora, S Merler, C Masini, R De Vivo, L Milesi, F Spina, M Rizzo, I Sperduti, G Fornarini, G Tortora

Annals of Oncology, Nov. 22

Abstract link

 

 

 

 

 

 

 

 

 

 

© 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.

Forse può anche interessarti

Privacy Overview
AIOM

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.